Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices

NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Add To Watchlist

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix To Introduce Quell 2.0: The Next Generation, Wearable Pain Relief Technology at PAINWeek 2018

PR Newswire September 4, 2018

NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB

GlobeNewswire August 29, 2018

NeuroMetrix Reports Presentation of Clinical and Scientific Data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference

GlobeNewswire August 28, 2018

NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City

GlobeNewswire August 27, 2018

NeuroMetrix Announces Participation at the 20th Annual Global Investment Conference in New York City September 4 - 6th, 2018

GlobeNewswire August 23, 2018

NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare

GlobeNewswire August 21, 2018

NeuroMetrix Reports Q2 2018 Financial Results

GlobeNewswire July 19, 2018

NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call

GlobeNewswire July 12, 2018

NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology

GlobeNewswire July 5, 2018

NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards

GlobeNewswire June 28, 2018

NeuroMetrix Reports Publication of New Clinical Studies on DPNCheck

GlobeNewswire June 26, 2018

NeuroMetrix Report Highlights Stigma Faced by Chronic Pain Community around Opioid Use, Desire for Alternative Treatments

GlobeNewswire June 21, 2018

NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare

GlobeNewswire June 19, 2018

Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress

GlobeNewswire May 3, 2018

NeuroMetrix, Inc. to Participate in Upcoming Disruptive Growth & Healthcare Conference in New York City

GlobeNewswire May 1, 2018

NeuroMetrix Reports Q1 2018 Financial Results

GlobeNewswire April 19, 2018

NeuroMetrix, Inc. to Host Earnings Call

Accesswire April 19, 2018

NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting

GlobeNewswire April 18, 2018

NeuroMetrix, Inc. Announces Date for 2018 First Quarter Financial Results Conference Call

GlobeNewswire April 11, 2018

NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief

GlobeNewswire April 10, 2018